Sage Healthcare Press Releases - EIN Presswire - Press Release Distribution Service

Published on May 8, 2024 - 07:00 GMT

The Sage Group Expands Team in Japan with a New Life Sciences Dealmaking Partnership with E-Projection Group

The Sage Group has announced a strategic partnership with E-Projection Group, Tokyo, to facilitate East/West Global deals in healthcare and life sciences. LONDON, UNITED KINGDOM, May 8, 2024 /⁨EINPresswire.com⁩/ -- The Sage Group today announced that it …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 28, 2023 - 10:58 GMT

Conceptomed Announces SalivaPOD™ for Collection of Human Saliva Samples for Personalised Diagnostics and Genetic Testing

Conceptomed has announced the launch of SalivaPOD™ for saliva collection, a growing use paradigm in personalized diagnostics and genetic testing. BALLSTAD, NORWAY, September 28, 2023 /⁨EINPresswire.com⁩/ -- Conceptomed, a private Norwegian medtech …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 10, 2023 - 11:03 GMT

AI Drug Discovery Pioneer Intellomx Joins Johnson & Johnson Innovation (JLABS)

Intellomx is pleased to announce that it has joined Johnson & Johnson Innovation (JLABS), a premier life science incubator program. NOTTINGHAM, UNITED KINGDOM, August 10, 2023 /⁨EINPresswire.com⁩/ -- Intelligent Omics Ltd (Intellomx) is pleased to …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 19, 2023 - 11:12 GMT

Intelligent OMICS, a leading UK-based AI pharma company, announces the appointment of Dr Robert Grundy as CEO

Intelligent OMICS ("Intellomx"; https://www.intellomx.com), a leading AI drug discovery company, is delighted to announce Dr Robert Grundy as their new CEO. NOTTINGHAM, UNITED KINGDOM, April 19, 2023 /⁨EINPresswire.com⁩/ -- Intelligent OMICS (…

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on December 20, 2022 - 17:42 GMT

Intellomx Receives Coveted Approval in China for its Novel Diagnostic Study on Detection of Latent Luberculosis

Intellomx have received Chinese government approval for a novel clinical diagnostics study for TB, to distinguish patients with latent TB using biomarkers. NOTTINGHAM, UK, December 20, 2022 /⁨EINPresswire.com⁩/ -- The Ministry of Science & Technology …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 12, 2022 - 08:00 GMT

AeroNeph Therapeutics Announces Successful MBO and Global Search for Strategic Partners for Novel Renal Disease Drugs

AeroNeph Therapeutics (“AeroNeph”; www.aeronephtx.com), a pioneer in discovery of renal disease assets, has announced its MBO and corporate launch in the USA. BIRMINGHAM, ALABAMA, UK, September 12, 2022 /⁨EINPresswire.com⁩/ -- AeroNeph Therapeutics (“ …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 12, 2022 - 07:00 GMT

EpiAxis Therapeutics Enters Strategic Partnership on Prostate Cancer with Canada's University Health Newtork (UHN)

EpiAxis Therapeutics and Canada's University Health Network have entered a collaboration to study a new epigenetics approach to prostate cancer treatment. SYDNEY, AUSTRALIA, September 12, 2022 /⁨EINPresswire.com⁩/ -- EpiAxis Therapeutics, a leading …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 9, 2022 - 06:00 GMT

Kinnov Therapeutics Announces Positive Phase 2 Outcome: Key Milestone with Lead Drug KT-110 for Alcohol Use Disorder

KINNOV Therapeutics has reached a key clinical milestone for treatment of Alcohol Use Disorder with a Phase 2 clinical study for its game changing drug KT-110. PARIS, FRANCE, June 9, 2022 /⁨EINPresswire.com⁩/ -- KINNOV Therapeutics (“Kinnov”) announces it …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 9, 2022 - 06:00 GMT

EpiAxis Therapeutics Announces Positive Clinical Trial Data for its New Drug Program to Inhibit Metastatic Breast Cancer

EpiAxis Therapeutics has announced a pioneering clinical study, showing that an epigenetic inhibitor combined with chemotherapy can treat metastatic cancer. SYDNEY, AUSTRALIA, June 9, 2022 /⁨EINPresswire.com⁩/ -- EpiAxis Therapeutics has announced the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 2, 2022 - 07:00 GMT

Paravir Announces Launch of Revolutionary New Anti-Microbial Material for Healthcare and PPE Applications

Paravir announced the successful development and launch of its new innovative technology for production of fabric with astonishing anti-microbial properties. CAMBRIDGE, UNITED KINGDOM, March 2, 2022 /⁨EINPresswire.com⁩/ -- Paravir Limited (“Paravir, https …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 2, 2022 - 07:00 GMT

Senior Government advisor and investor joins leading UK AI company Intelligent OMICS to Lead Business Development

Intelligent OMICS, a leading UK-based AI company, is delighted to announce the appointment of Dr Robert Grundy BSc PhD FRSB as VP Business Development. NOTTINGHAM, UNITED KINGDOM, March 2, 2022 /⁨EINPresswire.com⁩/ -- Intelligent OMICS ("Intellomx…

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 20, 2022 - 08:00 GMT

Paravir Announces Launch of Its’ Novel Anti-Microbial Non-Woven Fabric for Healthcare and PPE Applications

Paravir Launches Innovative Materials Technology for Preventing the Spread of Infectious Disease Using Novel Anti-Pathogenic Composite Material CAMBRIDGE, UNITED KINGDOM, January 20, 2022 /⁨EINPresswire.com⁩/ -- Paravir Limited (“Paravir"; https:// …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 23, 2021 - 08:40 GMT

Camstent Announces Initiation of a MultiCentre Clinical Study for Novel Anti-Bacterial Coated Foley Catheter Technology

Camstent has announced the initiation of clinical studies utilising its novel infection-resistant polymer coating for silicon-based medical products. BEDFORD, UNITED KINGDOM, September 23, 2021 /⁨EINPresswire.com⁩/ -- Camstent has announced the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 6, 2021 - 07:00 GMT

Exhalation Technology Announces CoronaCheck Lite for Rapid and Low Cost Testing of Covid-19 in Nasal Swabs and Saliva

CoronaCheck Lite is a unique, IP-protected, non-invasive, low cost test for rapid detection of CoronaVirus in under 5 minutes using nasal swabs and saliva CAMBRIDGE, UNITED KINGDOM, September 6, 2021 /⁨EINPresswire.com⁩/ -- Exhalation Technology (ETL), a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 10, 2021 - 08:22 GMT

Guangzhou Doublle Bioproduct Co Announces Clinical Update and Partner Search for Adenolysin for Head and Neck Cancer

Guangzhou Doublle Bioproduct gives a clinical and commercial update on its Adenolysin gene therapy asset for head and neck cancer as its seeks global partners NEW YORK, NEW YORK, USA, June 10, 2021 /⁨EINPresswire.com⁩/ -- Guangzhou Doublle Bio-Product Co …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 7, 2021 - 07:00 GMT

Exhalation Technology Announces Commercial Launch and Clinical Update on CoronaCheck - A Rapid Covid-19 Test

ETL has announced commercial launch and new results from a clinical study with its rapid (<5 mins) CoronaCheck diagnostic test for Covid-19 in exhaled breath. CAMBRIDGE, UNITED KINGDOM, April 7, 2021 /⁨EINPresswire.com⁩/ -- Exhalation Technology (ETL), …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 1, 2021 - 08:00 GMT

Zhimeng Biopharma Announces Global Partner Search for its' Development of a Cure for Chronic Hepatitis B Virus Infection

Zhimeng Biopharma is developing ZM-H1505R, an oral Hepatitis B Virus capsid formation inhibitor, for treating patients with chronic hepatitis B virus infection. SHANGHAI, CHINA, March 1, 2021 /⁨EINPresswire.com⁩/ -- Following a strategic review of its …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 19, 2021 - 10:03 GMT

Squarex Announces End of Phase 2 Meeting with FDA for its Cold Sore Prevention Asset

Squarex Pharma announced updated results from its successful Phase 2 clinical study on humans with its novel asset SQX770 for prevention of cold sores. ST PAUL, MINNESOTA, USA, January 19, 2021 /⁨EINPresswire.com⁩/ -- Squarex Pharma (SQX), a St. Paul, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on January 4, 2021 - 08:00 GMT

Exhalation Technology Updates on Groundbreaking Clinical Trial for CoronaCheck – A Rapid (<5 min) Covid-19 Breath Test

New clinical data on the CoronaCheck Covid-19 exhaled breath test shows absolute specificity and sensitivity in a test taking under 5 minutes at under $10. CAMBRIDGE, UNITED KINGDOM, January 4, 2021 /⁨EINPresswire.com⁩/ -- Exhalation Technology (ETL), a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 2, 2020 - 10:17 GMT

Exhalation Technology (ETL) Announces New Clinical Trial for CoronaCheck™ – A Rapid Covid-19 Test for Exhaled Breath

ETL announced a new clinical study with its novel CoronaCheck™ test for Covid-19, aiming for a sub-5 minute test of high specificity and sensitivity CAMBRIDGE, UNITED KINGDOM, November 2, 2020 /⁨EINPresswire.com⁩/ -- Exhalation Technology (ETL), based in …

Distribution channels: Aviation & Aerospace Industry, Banking, Finance & Investment Industry ...